Patients with Advanced Pancreatic Cancer and Hyperbilirubinaemia: Review and German Expert Opinion on Treatment with nab-Paclitaxel plus Gemcitabine (vol 38, pg 596, 2015)

被引：0
|
作者：
Vogel, Arndt [1 ]
Kullmann, Frank [2 ]
Kunzmann, Volker [3 ]
Al-Batrand, Salah-Eddin [4 ]
Oettle, Helmut [5 ]
Plentz, Ruben [6 ]
Siveke, Jens [7 ]
Springfeld, Christoph [8 ]
Riess, Hanno [9 ]
机构：
[1] Hannover Med Sch, Klin Gastroenterol Hepatol & Endokrinol, Hannover, Germany
[2] Klinikum Weiden, Med Klin 1, Weiden, Germany
[3] Univ Klinikum, Med Klin & Poliklin 2, Schwerpunkt Med Onkol, Wurzburg, Germany
[4] Univ Canc Ctr, Krankenhaus Nordwest, Frankfurt, Germany
[5] Onkol Schwerpunktpraxis, Friedrichshafen, Germany
[6] Univ Clin Tubingen, Tubingen, Germany
[7] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 2, D-80290 Munich, Germany
[8] Univ Heidelberg Hosp, Natl Ctr Tumor Dis, Heidelberg, Germany
[9] Charite, Med Klin Schwerpunkt Hamatol Onkol & Tumorimmunol, Berlin, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2015年 / 38卷 / 12期
关键词：
D O I：
10.1159/000442191
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：691 / 691
页数：1
相关论文
共 50 条
  • [1] Patients with Advanced Pancreatic Cancer and Hyperbilirubinaemia: Review and German Expert Opinion on Treatment with nab-Paclitaxel plus Gemcitabine
    Vogel, Arndt
    Kullmann, Frank
    Kunzmann, Volker
    Riess, Hanno
    Al-Batran, Salah-Eddin
    Oettle, Helmut
    Plentz, Ruben
    Siveke, Jens
    Springfeld, Christoph
    ONCOLOGY RESEARCH AND TREATMENT, 2015, 38 (11) : 596 - 603
  • [2] Reinitiating nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer
    Borazanci, Erkut
    Schroeder, Katy
    Jameson, Gayle S.
    Ramanathan, Ramesh K.
    Von Hoff, Daniel D.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [3] Maintenance treatment with gemcitabine after gemcitabine plus Nab-paclitaxel in advanced pancreatic cancer
    Kodama, Tomoko
    Nakazawa, Junichi
    Kawahira, Masahiro
    Ymasuji, Akihiro
    Iwashita, Yuji
    Hori, Takeshi
    Kawahira, Machiko
    Arima, Shiho
    Tubouchi, Hirohito
    Ido, Akio
    ANNALS OF ONCOLOGY, 2022, 33 : S484 - S484
  • [4] Predictors of vulnerability to nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer
    Iede, Kiyotsugu
    Yamada, Terumasa
    Tominaga, Shusei
    ANNALS OF ONCOLOGY, 2023, 34 : S1453 - S1453
  • [5] Survival of patients with advanced pancreatic cancer is increased by nab-paclitaxel plus gemcitabine
    Nature Reviews Gastroenterology & Hepatology, 2013, 10 (12) : 695 - 695
  • [6] The retrospective analysis of gemcitabine plus nab-paclitaxel in advanced pancreatic cancer
    Ueno, M.
    Kobayashi, S.
    Ohkawa, S.
    Tezuka, S.
    Moriya, S.
    Morimoto, M.
    ANNALS OF ONCOLOGY, 2015, 26 : 67 - 67
  • [7] FOLFIRINOX for Advanced Pancreatic Cancer Patients After Nab-Paclitaxel Plus Gemcitabine Failure
    Matsumoto, Toshihiko
    Kurioka, Yusuke
    Okazaki, Ukyo
    Matsuo, Yu
    Kimura, Shogo
    Miura, Kou
    Tsuduki, Takao
    Takagi, Shinjiro
    Takatani, Masahiro
    Morishita, Hirofumi
    PANCREAS, 2020, 49 (04) : 574 - 578
  • [8] Gemcitabine plus nab-paclitaxel vs. FOLFIRINOX for patients with advanced pancreatic cancer
    Junko Tahara
    Kyoko Shimizu
    Nao Otsuka
    Junichi Akao
    Yukiko Takayama
    Katsutoshi Tokushige
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 245 - 250
  • [9] Gemcitabine plus nab-paclitaxel vs. FOLFIRINOX for patients with advanced pancreatic cancer
    Tahara, Junko
    Shimizu, Kyoko
    Otsuka, Nao
    Akao, Junichi
    Takayama, Yukiko
    Tokushige, Katsutoshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (02) : 245 - 250
  • [10] Gemcitabine plus Nab-Paclitaxel with chemoradiation in locally advanced pancreatic cancer (LAPC)
    Olowokure, Olugbenga
    Torregroza-Sanchez, Maria Patricia
    Bedoya-Apraez, Ivan Dario
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2013, 4 (02) : E16 - E18
12345